Squarepoint Ops LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$584,862
+129.9%
128,541
+208.8%
0.00%0.0%
Q1 2023$254,372
-92.8%
41,632
-88.7%
0.00%
-94.4%
Q3 2022$3,528,000
+882.7%
368,310
+1609.4%
0.02%
+800.0%
Q1 2022$359,000
-84.8%
21,546
-82.6%
0.00%
-66.7%
Q4 2021$2,359,000
+128.1%
123,591
+194.5%
0.01%
+100.0%
Q3 2021$1,034,000
+23.2%
41,961
+30.2%
0.00%0.0%
Q2 2021$839,000
-41.5%
32,234
-28.9%
0.00%
-66.7%
Q1 2021$1,435,000
+245.0%
45,327
+258.6%
0.01%
+50.0%
Q3 2020$416,000
-88.5%
12,640
-90.4%
0.01%
-89.8%
Q2 2020$3,617,000
+1673.0%
131,770
+1834.9%
0.06%
+1080.0%
Q1 2020$204,000
-85.4%
6,810
-86.5%
0.01%
-37.5%
Q4 2019$1,393,000
+120.4%
50,320
+44.9%
0.01%
+33.3%
Q3 2019$632,000
-52.7%
34,728
-36.3%
0.01%
-53.8%
Q2 2019$1,337,000
-58.2%
54,515
-83.8%
0.01%
-61.8%
Q1 2019$3,201,000
+67.1%
336,627
+55.5%
0.03%
+54.5%
Q4 2018$1,916,000
-32.7%
216,452
-14.4%
0.02%
-35.3%
Q3 2018$2,846,000
+54.4%
253,000
+75.7%
0.03%
+41.7%
Q2 2018$1,843,000
+2.4%
144,000
+35.2%
0.02%
-17.2%
Q1 2018$1,800,000
+1507.1%
106,500
+663.7%
0.03%
+1350.0%
Q4 2017$112,000
-66.6%
13,946
-67.7%
0.00%
-66.7%
Q3 2017$335,00043,2060.01%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders